Lakewood-Amedex Biotherapeutics Inc (LABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 03-2000 | 03-1999 | 03-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,848 | -4,855 | 170 | -4,940 | -3,270 |
| Depreciation Amortization | 120 | 52 | 4,890 | 4,360 | 770 |
| Accounts payable and accrued liabilities | 215 | -333 | N/A | N/A | N/A |
| Other Working Capital | 542 | -1,084 | -3,690 | 3,870 | N/A |
| Other Operating Activity | 1,026 | 497 | 2,000 | 340 | 2,240 |
| Operating Cash Flow | $-1,945 | $-5,723 | $3,370 | $3,630 | $-260 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2 | -1,320 | -1,430 | N/A |
| Net Acquisitions | N/A | N/A | -13,140 | -1,630 | N/A |
| Purchase Of Investment | N/A | -4,334 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 8,260 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 70 | 5,210 | 1,050 |
| Investing Cash Flow | $N/A | $3,925 | $-14,390 | $2,150 | $1,050 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,500 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -50 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 11,640 | -5,980 | -450 |
| Financing Cash Flow | $1,500 | $-50 | $11,640 | $-5,980 | $-450 |
| Exchange Rate Effect | N/A | N/A | -10 | -20 | -10 |
| Beginning Cash Position | 681 | 2,530 | 760 | 980 | 170 |
| End Cash Position | 236 | 681 | 1,370 | 760 | 490 |
| Net Cash Flow | $-445 | $-1,849 | $600 | $-220 | $320 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,945 | -5,723 | 3,370 | 3,630 | -260 |
| Capital Expenditure | N/A | -2 | N/A | N/A | N/A |
| Free Cash Flow | -1,945 | -5,725 | 3,370 | 3,630 | -260 |